Sökning: WFRF:(Nordstrom Britta)
> (2014) >
Examestane in advan...
Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)
-
- Lindemann, Kristina (författare)
- Oslo University Hospital, Norway
-
- Malander, Susanne (författare)
- Lund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,University of Lund Hospital, Sweden
-
- Christensen, Rene D. (författare)
- University of Southern Denmark, Denmark
-
visa fler...
-
- Mirza, Mansoor R. (författare)
- University of Copenhagen Hospital, Denmark
-
- Kristensen, Gunnar B. (författare)
- Oslo University Hospital, Norway Oslo University Hospital, Norway
-
- Åvall-Lundqvist, Elisabeth (författare)
- Karolinska Institutet,Östergötlands Läns Landsting,Linköpings universitet,Avdelningen för kliniska vetenskaper,Hälsouniversitetet,Onkologiska kliniken US,Karolinska University Hospital, Sweden
-
- Vergote, Ignace (författare)
- University Hospital Leuven, Belgium University Hospital Leuven, Belgium
-
- Rosenberg, Per (författare)
- Östergötlands Läns Landsting,Linköpings universitet,Avdelningen för kliniska vetenskaper,Hälsouniversitetet,Onkologiska kliniken US
-
- Boman, Karin (författare)
- University Hospital, Sweden
-
- Nordstrom, Britta (författare)
- Karolinska University Hospital, Sweden
-
visa färre...
-
(creator_code:org_t)
- 2014-02-05
- 2014
- Engelska.
-
Ingår i: BMC Cancer. - : Springer Science and Business Media LLC. - 1471-2407. ; 14
- Relaterad länk:
-
https://portal.resea... (primary) (free)
-
visa fler...
-
http://dx.doi.org/10... (free)
-
https://bmccancer.bi...
-
https://liu.diva-por... (primary) (Raw object)
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: We evaluated the efficacy and safety of the aromatase inhibitor exemestane in patients with advanced, persistent or recurrent endometrial carcinoma. Methods: We performed an open-label one-arm, two-stage, phase II study of 25 mg of oral exemestane in 51 patients with advanced (FIGO stage III-IV) or relapsed endometrioid endometrial cancer. Patients were stratified into subsets of estrogen receptor (ER) positive and ER negative patients. Results: Recruitment to the ER negative group was stopped prematurely after 12 patients due to slow accrual. In the ER positive patients, we observed an overall response rate of 10%, and a lack of progression after 6 months in 35% of the patients. No responses were registered in the ER negative patients, and all had progressive disease within 6 months. For the total group of patients, the median progression free survival (PFS) was 3.1 months (95% CI: 2.0-4.1). In the ER positive patients the median PFS was 3.8 months (95% CI: 0.7-6.9) and in the ER negative patients it was 2.6 months (95% CI: 2.1-3-1). In the ER positive patients the median overall survival (OS) time was 13.3 months (95% CI: 7.7-18.9), in the ER negative patients the corresponding numbers were 6.1 months (95% CI: 4.1-8.2). Treatment with exemestane was well tolerated. Conclusion: Treatment of estrogen positive advanced or recurrent endometrial cancer with exemestane, an aromatase inhibitor, resulted in a response rate of 10% and lack of progression after 6 months in 35% of the patients.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- Aromatase inhibitor
- Exemestane
- Endometrial cancer
- Treatment
- Phase II
- study
- Aromatase inhibitor; Exemestane; Endometrial cancer; Treatment; Phase II study
- MEDICINE
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Lindemann, Krist ...
-
Malander, Susann ...
-
Christensen, Ren ...
-
Mirza, Mansoor R ...
-
Kristensen, Gunn ...
-
Åvall-Lundqvist, ...
-
visa fler...
-
Vergote, Ignace
-
Rosenberg, Per
-
Boman, Karin
-
Nordstrom, Britt ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
BMC Cancer
- Av lärosätet
-
Lunds universitet
-
Linköpings universitet
-
Karolinska Institutet